• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

变化世界中的再现和新发疾病。

Resurgent and emergent disease in a changing world.

作者信息

Cohen M L

机构信息

Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.

出版信息

Br Med Bull. 1998;54(3):523-32. doi: 10.1093/oxfordjournals.bmb.a011707.

DOI:10.1093/oxfordjournals.bmb.a011707
PMID:10326281
Abstract

Emerging infectious diseases pose important public health problems for both the developed and developing world. Many new or previously unrecognized bacterial, fungal, viral, and parasitic diseases have emerged within the past two decades. At the same time, many once-controlled infections have re-emerged or become resistant to antimicrobial therapy. This emergence is the result of changes in society, technology, the environment, and the microbes themselves, and these changes have had often unpredictable consequences. Important factors influencing emergence include changes in human demographics and behaviour, changes in technology and industry, changes in economic development and land use, increasing and rapid international travel and commerce, microbial adaptation and change, and the breakdown of public health measures. Addressing emerging infectious diseases will require international and interdisciplinary partnerships to build an appropriate infrastructure to detect and respond to these often unanticipated threats to health.

摘要

新发传染病对发达国家和发展中国家都构成了重大的公共卫生问题。在过去二十年中,出现了许多新的或以前未被认识的细菌、真菌、病毒和寄生虫病。与此同时,许多曾经得到控制的感染又重新出现或对抗菌治疗产生了耐药性。这种情况的出现是社会、技术、环境和微生物自身变化的结果,而这些变化往往产生不可预测的后果。影响疾病出现的重要因素包括人口统计学和人类行为的变化、技术和产业的变化、经济发展和土地利用的变化、日益频繁和迅速的国际旅行与商业活动、微生物的适应与变化,以及公共卫生措施的失效。应对新发传染病需要国际和跨学科的合作,以建立适当的基础设施,来检测和应对这些往往意想不到的健康威胁。

相似文献

1
Resurgent and emergent disease in a changing world.变化世界中的再现和新发疾病。
Br Med Bull. 1998;54(3):523-32. doi: 10.1093/oxfordjournals.bmb.a011707.
2
Changing patterns of infectious disease.传染病模式的变化
Nature. 2000 Aug 17;406(6797):762-7. doi: 10.1038/35021206.
3
Emerging and re-emerging infections.新出现和再出现的感染性疾病。
Indian J Pathol Microbiol. 1997 Oct;40(4):569-81.
4
Epidemiological factors influencing the emergence of antimicrobial resistance.影响抗菌药物耐药性产生的流行病学因素。
Ciba Found Symp. 1997;207:223-31; discussion 231-7.
5
Emerging foodborne diseases.新出现的食源性疾病。
Emerg Infect Dis. 1997 Jul-Sep;3(3):285-93. doi: 10.3201/eid0303.970304.
6
A Quarter Century of Emerging Infectious Diseases - Where Have We Been and Where Are We Going?新兴传染病的二十五年——我们曾在何处,又将去往何方?
Acta Med Acad. 2018 May;47(1):117-130. doi: 10.5644/ama2006-124.222.
7
Foodborne diseases. Emerging pathogens and trends.食源性疾病。新出现的病原体与趋势。
Infect Dis Clin North Am. 1998 Mar;12(1):199-216. doi: 10.1016/s0891-5520(05)70418-9.
8
Infectious diseases -- new and ancient threats to world health.传染病——对世界健康构成新的和古老的威胁。
Popul Bull. 1997 Jul;52(2):1-52.
9
The emerging infectious diseases.新出现的传染病。
Physician Assist. 1995 Dec;19(12):73, 77-8, 80-1.
10
Emerging infectious diseases: vulnerabilities, contributing factors and approaches.新发传染病:脆弱性、促成因素及应对方法
Expert Rev Anti Infect Ther. 2004 Apr;2(2):299-316. doi: 10.1586/14787210.2.2.299.

引用本文的文献

1
Characteristics of the 100 largest modern zoonotic disease outbreaks.100 大现代人畜共患病暴发的特征。
Philos Trans R Soc Lond B Biol Sci. 2021 Nov 8;376(1837):20200535. doi: 10.1098/rstb.2020.0535. Epub 2021 Sep 20.
2
Swine virome on rural backyard farms in Mexico: communities with different abundances of animal viruses and phages.墨西哥农村后院农场的猪病毒组:具有不同动物病毒和噬菌体丰度的群落。
Arch Virol. 2021 Feb;166(2):475-489. doi: 10.1007/s00705-020-04894-y. Epub 2021 Jan 4.
3
In vitro antimicrobial activity of extracts from plants used traditionally in South Africa to treat tuberculosis and related symptoms.
南非传统用于治疗肺结核和相关症状的植物提取物的体外抗菌活性。
Evid Based Complement Alternat Med. 2013;2013:840719. doi: 10.1155/2013/840719. Epub 2013 Mar 5.
4
Shaping cities for health: complexity and the planning of urban environments in the 21st century.塑造健康城市:复杂性与21世纪城市环境规划
Lancet. 2012 Jun 2;379(9831):2079-108. doi: 10.1016/S0140-6736(12)60435-8. Epub 2012 May 30.
5
Molecular typing in public health laboratories: from an academic indulgence to an infection control imperative.公共卫生实验室中的分子分型:从学术消遣到感染控制的必要手段。
J Prev Med Public Health. 2012 Jan;45(1):1-7. doi: 10.3961/jpmph.2012.45.1.1. Epub 2012 Jan 31.
6
Environmental determinants of infectious disease: a framework for tracking causal links and guiding public health research.传染病的环境决定因素:追踪因果关系及指导公共卫生研究的框架
Environ Health Perspect. 2007 Aug;115(8):1216-23. doi: 10.1289/ehp.9806.
7
In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci.新型酮内酯ABT-773对多重耐药革兰氏阳性球菌的体外活性
Antimicrob Agents Chemother. 2001 Dec;45(12):3640-3. doi: 10.1128/AAC.45.12.3640-3643.2001.
8
Density-dependent decline of host abundance resulting from a new infectious disease.一种新型传染病导致宿主数量因密度依赖而下降。
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5303-6. doi: 10.1073/pnas.080551197.